| __timestamp | Evotec SE | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 89496000 | 64538000 |
| Thursday, January 1, 2015 | 127677000 | 71914000 |
| Friday, January 1, 2016 | 164507000 | 108973000 |
| Sunday, January 1, 2017 | 257630000 | 141102000 |
| Monday, January 1, 2018 | 375405000 | 251453000 |
| Tuesday, January 1, 2019 | 446437000 | 120282000 |
| Wednesday, January 1, 2020 | 500924000 | 186419000 |
| Friday, January 1, 2021 | 618034000 | 277133000 |
| Saturday, January 1, 2022 | 751448000 | 196245000 |
| Sunday, January 1, 2023 | 781426000 | 131314000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Evotec SE has consistently outperformed Ligand Pharmaceuticals Incorporated in annual revenue. Starting in 2014, Evotec's revenue was approximately 39% higher than Ligand's. By 2023, this gap widened significantly, with Evotec's revenue being nearly six times that of Ligand's.
Evotec SE has shown a remarkable upward trajectory, with an average annual growth rate of around 20%. In contrast, Ligand Pharmaceuticals has experienced more modest growth, averaging about 10% annually. This divergence highlights Evotec's strategic positioning and market adaptability.
The data underscores the importance of innovation and strategic partnerships in the biotech sector. As Evotec continues to expand its global footprint, Ligand may need to reassess its strategies to remain competitive.
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
BeiGene, Ltd. or Evotec SE: Who Leads in Yearly Revenue?
Walgreens Boots Alliance, Inc. or Ligand Pharmaceuticals Incorporated: Who Leads in Yearly Revenue?
Ascendis Pharma A/S and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Revenue Showdown: Lantheus Holdings, Inc. vs Evotec SE
Perrigo Company plc and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bausch Health Companies Inc. vs Evotec SE
Ligand Pharmaceuticals Incorporated and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Cost Insights: Breaking Down Ligand Pharmaceuticals Incorporated and Evotec SE's Expenses
Comparing Revenue Performance: Ligand Pharmaceuticals Incorporated or Novavax, Inc.?
Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.: A Comprehensive Revenue Analysis